Tolga Tanguler is EVP, Chief Commercial Officer of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 25,992 shares of ALNY, which is worth approximately $11.8 Million. The most recent transaction as insider was on Jul 05, 2022, when has been sold 1,754 shares (Common Stock) at a price of $150.0 per share, resulting in proceeds of $263,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26K
7.21% 3M change
122.92% 12M change
Total Value Held $11.8 Million

Tolga Tanguler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 05 2022
SELL
Open market or private sale
$263,100 $150.0 p/Share
1,754 Reduced 50.0%
1,754 Common Stock
Feb 02 2022
SELL
Payment of exercise price or tax liability
$219,609 $144.67 p/Share
1,518 Reduced 30.2%
3,508 Common Stock
Feb 01 2022
BUY
Exercise of conversion of derivative security
-
5,026 Added 50.0%
5,026 Common Stock

Also insider at

LXEO
Lexeo Therapeutics, Inc.
TT

Tolga Tanguler

EVP, Chief Commercial Officer
Cambridge, MA

Track Institutional and Insider Activities on ALNY

Follow ALNYLAM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNY shares.

Notify only if

Insider Trading

Get notified when an Alnylam Pharmaceuticals, Inc. insider buys or sells ALNY shares.

Notify only if

News

Receive news related to ALNYLAM PHARMACEUTICALS, INC.

Track Activities on ALNY